MediWound has commenced a pivotal, multicentre Phase III VALUE trial to assess its bioactive debridement therapy, EscharEx, ...
Phase III trial to assess the efficacy and safety of EscharEx® for debridement and facilitation of active wound closure ...
Phase III trial to assess the efficacy and safety of EscharEx® for debridement and facilitation of active wound closure Interim analysis planned after 65% of patients complete treatment, expected in ...
The Punch on MSN4d
Benefits of lavender essential oilHe told me about a patient who had recently benefited from his high blood pressure regulator herb and subsequently referred ...
Once the bone was safely back inside the man, doctors worked to stem off any infections, according to the report. For one month, the medical team gave antibiotics, irrigated the wound, changed the man ...
YAVNE, Israel - MediWound Ltd. (NASDAQ:MDWD), a biopharmaceutical company specializing in enzymatic therapies for tissue repair, has launched a Phase III clinical trial for its product EscharEx®, ...
The infection finally was “controlled,” doctors said, and the first signs of healing appeared as granulation tissue in the wound. The 25-year-old went back into the operating room, and doctors ...
Peppermint essential oil is a powerful natural medicine that has a hydrophobic and volatile nature. Now, research suggests that its healing properties can be enhanced with the help of nanotechnology.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback